Family Medicine Doctors in Comstock Park, MI Accepting Medicare

2 Family Medicine doctors found. Showing 1 - 2

Gary N Sackett, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4200 Division Ave N, Comstock Park, MI 49321 Phone: 616-252-1600    Fax: 616-252-1666

Janice K Wabeke, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4200 Division Ave N, Comstock Park, MI 49321 Phone: 616-252-1600    Fax: 616-252-1666

News Archive

Researchers identify several factors that prevent use of sEMG in clinical neurorehabilitation

Kessler Foundation researchers have identified several practical and technical barriers to the widespread use of surface electromyography (sEMG) in clinical neurorehabilitation.

Parents comfortable with vaccination for STIs for their children

Parents are generally accepting of the hypothetical scenario of vaccinating their adolescent children against infection, whether the infection is sexually transmitted or not, according to a study in the February issue of The Archives of Pediatrics and Adolescent Medicine.

Study: One-third of bacterial infections in patients with cirrhosis induced by MDR bacteria

A worldwide study initiated to investigate the epidemiology and outcomes of bacterial infections in hospitalized patients with liver cirrhosis has reported a prevalence of multi-drug-resistant bacteria of 34% and significant regional differences in the risk of developing a multi-drug-resistant infection.

Israeli Supreme Court dismisses Taro's appeal in favor of Sun Pharma

Sun Pharmaceutical Industries Ltd. today announced that the Supreme Court of Israel has unanimously dismissed the appeal by Taro Pharmaceutical Industries Ltd. of the previous ruling by the Tel-Aviv District Court holding that the Israeli special tender offer (STO) rules do not apply to the Tender Offer by Sun's subsidiary, Alkaloida Chemical Company Exclusive Group Ltd., to purchase all outstanding Ordinary Shares of Taro for USD 7.75 net per Ordinary Share in cash.

NPS Pharmaceuticals' Natpara gets orphan drug designation for treatment of hypoparathyroidism

NPS Pharmaceuticals, Inc., a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that the European Commission has granted orphan drug designation to Natpara (recombinant human parathyroid hormone (rhPTH[1-84]) for the treatment of hypoparathyroidism.

Read more Medical News

› Verified 1 days ago